AstraZeneca said it will buy U.S.-based clinical-stage biopharmaceutical firm CinCor Pharma in a deal valued at about $1.8 billion https://t.co/69Ov5sRxXP pic.twitter.com/N6NsbrDSaz— Reuters (@Reuters) January 9, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


